← Back to Search

Light-deprivation Utilized to Mitigate Amblyopia (LUMA Trial)

N/A
Waitlist Available
Led By Benjamin T Backus, PhD
Research Sponsored by State University of New York College of Optometry
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 times during the 2 months before sequestration, 4 times during 12 months after sequestration
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve vision in adults with lazy eye by having them spend time in complete darkness followed by specific vision exercises. The darkness helps make the brain more adaptable, and the exercises help improve vision. The study targets adults with lazy eye who do not have misaligned eyes.

Eligible Conditions
  • Lazy Eye

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three times during the 2 months before sequestration to establish baseline, and again after sequestration: once a week for 2 weeks, then once a month for 2 months, then once every 3 months until study completion (at approximately 1 year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and three times during the 2 months before sequestration to establish baseline, and again after sequestration: once a week for 2 weeks, then once a month for 2 months, then once every 3 months until study completion (at approximately 1 year) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in Backus Lab Stereoacuity Assessment
Change from baseline in acuity as measured using M&S Technologies automated ETDRS acuity test
Eye
Secondary study objectives
Binocular motor fusion assessment
Other study objectives
Daily self-report of visual hallucinations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Visual Deprivation - 10 daysExperimental Treatment2 Interventions
10 days of visual deprivation followed by vision training
Group II: Vision Training OnlyActive Control1 Intervention
Vision training without visual deprivation

Find a Location

Who is running the clinical trial?

State University of New York College of OptometryLead Sponsor
19 Previous Clinical Trials
1,128 Total Patients Enrolled
University of Maryland, College ParkOTHER
159 Previous Clinical Trials
46,455 Total Patients Enrolled
Nova Southeastern UniversityOTHER
101 Previous Clinical Trials
11,978 Total Patients Enrolled
National Eye Institute (NEI)NIH
558 Previous Clinical Trials
1,408,463 Total Patients Enrolled
Benjamin T Backus, PhDPrincipal InvestigatorGrad Ctr for Vision Research, SUNY College of Optometry
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top